Placebo for VIB4920

DRUG2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Lupus NephritisRheumatoid Arthritis

Phase 2

VIBRANT: VIB4920 for Active Lupus Nephritis

RecruitingNCT05201469

National Institute of Allergy and Infectious Diseases (NIAID)Lupus Nephritis

Start: 2022-05-16End: 2027-03-31Target: 74Updated: 2025-12-19

CD40L Antagonism in Rheumatoid Arthritis (RA)

TerminatedNCT05306353

National Institute of Allergy and Infectious Diseases (NIAID)Rheumatoid Arthritis

Start: 2023-07-25End: 2025-07-28Updated: 2026-01-29